Investment
Features
FeesSafety
Academy
More
Pluang+

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Company Fundamentals
20 Oct 2026
Alex Lavoie
View Source
Neutral
Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increase in EBITDA to MXN 6.10 billion, with an improved EBITDA margin of 67.8%. Passenger traffic declined 1.4%, less than the previous quarter's drop, but the CEO warned this does not signal a broad recovery. Growth was supported by non-aeronautical services and the Cross Border Xpress acquisition.

Grupo Aeroportuario del Pacífico's Q3 2026 earnings showed a 19.2% increase in EBITDA to MXN 6.10 billion with an improved margin of 67.8%. For readers following Industrials-sector US stocks on Pluang, here is the market snapshot as of Oct 21, 2026 03:11 WIB: out of 135 stocks, 88 rose and 47 fell. Notable movers include TRI at USD 113.43 (+4.80%, 100% Sell), NOC at USD 534.50 (+4.67%, 87% Buy), and FIX at USD 1,398.01 (-4.51%, 100% Buy).

More News

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
13 minutes ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
1 hour ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
2 hours ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
2 hours ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App